Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Runt-related transcription factor 1 (RUNX1) is a master regulatory protein crucial for blood cell development but also involved more broadly across tissues including bone formation and heart tissue remodeling. Its dysregulation—by mutation or chromosomal rearrangement—is strongly linked to several cancers including acute myeloid leukemia. Experimental small-molecule inhibitors exist but none are yet clinically approved.
Inhibition of RUNX1 transcriptional activity
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Runt-related Transcription Factor 1 (RUNX1).